A detailed history of Eagle Health Investments LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Eagle Health Investments LP holds 544,200 shares of EXAS stock, worth $32.3 Million. This represents 7.03% of its overall portfolio holdings.

Number of Shares
544,200
Previous 544,200 -0.0%
Holding current value
$32.3 Million
Previous $23 Million 61.16%
% of portfolio
7.03%
Previous 4.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $17.5 Million - $31.4 Million
423,200 Added 349.75%
544,200 $23 Million
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $6.81 Million - $8.93 Million
121,000 New
121,000 $8.36 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Eagle Health Investments LP Portfolio

Follow Eagle Health Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.